Anteris Technologies Global (NASDAQ:AVR) Releases Earnings Results, Misses Estimates By $0.09 EPS

Anteris Technologies Global (NASDAQ:AVR) released its quarterly earnings data on Tuesday. The company reported ($0.30) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.21) by ($0.09), FiscalAI reports. The business had revenue of $1.01 million for the quarter, compared to the consensus estimate of $1.50 million. Anteris Technologies Global had a negative net margin of 5,148.78% and a negative return on equity of 124.76%.

Anteris Technologies Global Price Performance

AVR traded up $0.21 during trading on Tuesday, hitting $9.17. The company’s stock had a trading volume of 1,096,833 shares, compared to its average volume of 1,175,484. The stock has a market cap of $892.61 million, a PE ratio of -4.11 and a beta of 1.79. The firm’s 50 day moving average price is $9.15 and its 200-day moving average price is $7.31. Anteris Technologies Global has a twelve month low of $3.17 and a twelve month high of $11.06.

Analyst Upgrades and Downgrades

AVR has been the subject of a number of recent research reports. Weiss Ratings reiterated a “sell (d-)” rating on shares of Anteris Technologies Global in a research report on Friday, May 29th. Barclays lifted their price target on shares of Anteris Technologies Global from $17.00 to $18.00 and gave the company an “overweight” rating in a research report on Friday, May 15th. Finally, Wall Street Zen raised Anteris Technologies Global from a “sell” rating to a “hold” rating in a research note on Saturday, May 16th. Four research analysts have rated the stock with a Buy rating and one has given a Sell rating to the stock. According to MarketBeat.com, Anteris Technologies Global has a consensus rating of “Moderate Buy” and a consensus target price of $16.00.

Insider Transactions at Anteris Technologies Global

In other news, major shareholder L1 Capital Pty Ltd sold 174,721 shares of Anteris Technologies Global stock in a transaction that occurred on Thursday, August 6th. The shares were sold at an average price of $8.10, for a total transaction of $1,415,240.10. Following the sale, the insider owned 5,439,000 shares in the company, valued at $44,055,900. This trade represents a 3.11% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Insiders have sold a total of 2,373,000 shares of company stock valued at $19,387,842 over the last three months. 4.50% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of AVR. ADAR1 Capital Management LLC increased its holdings in shares of Anteris Technologies Global by 526.9% in the 4th quarter. ADAR1 Capital Management LLC now owns 1,238,777 shares of the company’s stock valued at $6,181,000 after acquiring an additional 1,041,162 shares during the last quarter. Millennium Management LLC lifted its holdings in Anteris Technologies Global by 21.7% in the 4th quarter. Millennium Management LLC now owns 85,646 shares of the company’s stock valued at $427,000 after acquiring an additional 15,266 shares during the last quarter. Bridgeway Capital Management LLC acquired a new position in shares of Anteris Technologies Global in the 4th quarter worth $175,000. Price T Rowe Associates Inc. MD increased its position in shares of Anteris Technologies Global by 78.7% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 22,875 shares of the company’s stock worth $115,000 after acquiring an additional 10,073 shares in the last quarter. Finally, Barclays PLC lifted its position in shares of Anteris Technologies Global by 3.0% in the fourth quarter. Barclays PLC now owns 148,128 shares of the company’s stock worth $739,000 after purchasing an additional 4,289 shares in the last quarter.

About Anteris Technologies Global

Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.